Tirzepatide
Tirzepatide for police officers/firefighters/first respondersThe most effective weight loss medication available
Tirzepatide is a groundbreaking dual GLP-1/GIP agonist that delivers superior weight loss results. Clinical studies demonstrate average weight loss of up to 20.9% of body weight over 72 weeks.
Why Tirzepatide
Key Benefits
Ideal For:
How Tirzepatide Works
Tirzepatide's dual-action formula targets two key pathways for enhanced weight loss.
Dual GLP-1/GIP Action
Unique dual agonist activates both GLP-1 and GIP receptors, amplifying appetite suppression and metabolic benefits beyond single-receptor medications.
Appetite Regulation
Signals your brain's satiety centers to reduce hunger and cravings, making it easier to maintain a caloric deficit without constant willpower.
Metabolic Enhancement
Improves insulin sensitivity and glucose metabolism while promoting the body's natural fat-burning processes for sustained weight loss.
Dual GLP-1/GIP Action
Unique dual agonist activates both GLP-1 and GIP receptors, amplifying appetite suppression and metabolic benefits beyond single-receptor medications.
Appetite Regulation
Signals your brain's satiety centers to reduce hunger and cravings, making it easier to maintain a caloric deficit without constant willpower.
Metabolic Enhancement
Improves insulin sensitivity and glucose metabolism while promoting the body's natural fat-burning processes for sustained weight loss.
Beyond Weight Loss: Comprehensive Health Benefits
Lose Meaningful Weight
- Up to 21% average loss in trials¹
- Outperformed older GLP-1 medications²
- Based on 72-week SURMOUNT-1 study¹
Metabolic Reset
- Up to 93% reached healthy glucose targets²
- Improved insulin sensitivity in trials²
- Stronger overall metabolic control
Protect Your Heart
- Reduced risk of major cardiac events³
- Improved cholesterol and blood pressure³
- Supported by long-term outcomes data
Sleep Apnea Relief
- Tirzepatide is FDA-approved for moderate-to-severe OSA⁴
- Up to 51% achieved remission in trials⁴
- First active ingredient approved for OSA
*Clinical outcomes based on published tirzepatide trials, including SURMOUNT-1 (weight loss)¹, SURPASS-2 (glucose & metabolic health)², SURPASS-4 (cardiovascular outcomes)³, and SURMOUNT-OSA (sleep apnea)⁴. Compounded versions of Tirzepatide are not associated with Eli Lilly & Company and/or its genuine MOUNJARO® and/or ZEPBOUND® products. Compounded versions of Tirzepatide are not FDA approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy. GLP-1s may cause serious side effects, including possible thyroid tumors, including cancer. See the 'Important Safety Information' links below for more details.
Tirzepatide Pricing
All-in pricing. No hidden fees. No 'consultation charges.' Just what you see.
Every RespondWell Plan Includes:
- Free Provider Consultation
- Medication & supplies
- Free 2-day shipping
- Ongoing medical support
LegitScript CertifiedQuality You Can Trust
We only partner with licensed compounding pharmacies that meet top-tier standards for safety & precision, with routine third-party testing.
All medications are prepared in licensed 503A/503B compounding facilities in compliance with cGMP regulations.
- Licensed Pharmacies
- Potency Verified
- Sterility Tested
- Endotoxin Screened
- pH Balanced
Dosing & Administration
Tirzepatide is administered as a once-weekly subcutaneous injection. Your provider will start you at a lower dose and gradually increase to your target dose.
Typical Titration Schedule
Built for the Tactical Athlete
Because losing weight shouldn't mean losing strength.
Standard GLP-1 weight loss comes with a tradeoff: >25% of what you lose could be lean tissue, not fat⁵ — a footnote for an office worker, the wrong tissue to lose for someone who has to carry a partner out of a structure fire.
The Lean-Mass Problem
Our GLP-1s are compounded with glycine, an amino acid that activates mTORC1 — the central pathway for muscle protein synthesis — and has demonstrated preserved lean mass in preclinical models of caloric restriction.⁵,⁶ Glycine is thought to restore the muscle's anabolic response to protein under the kind of inflammatory stress that mirrors rapid weight loss.⁷ It also doubles as a buffering agent for a more comfortable injection.
More on Tirzepatide
Deeper dives from our editorial team — pricing, dosing, and the research behind it.
Frequently Asked Questions
Everything else worth knowing about Tirzepatide.
Not Quite Right? Check These Out
Different goals need different tools. Here's what else we've got.
About Our Medications
Our treatments contain active pharmaceutical ingredients that conform to USP (United States Pharmacopeia) monograph standards and are custom-compounded by licensed 503A and 503B pharmacies to meet your individual needs. Compounded medications are not FDA-approved finished drug products. The suggested formulations are provided for reference only and are based on formulations that have historically been prescribed by duly licensed prescribers. All medications are prepared in accordance with a valid prescription from a licensed healthcare provider following a medical consultation.
Medical Consultation Required
Our licensed medical providers will evaluate your health history and goals to determine the most appropriate treatment option for you. Prescriptions are subject to medical evaluation and are not guaranteed. If we are unable to prescribe treatment after your consultation, you pay zero. Independent clinical services provided by: Wasef Health, PC c/o Michael Wasef MD. Licensed in all 50 states + DC.
Clinical References
- 1Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216.
- 2Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503–515.
- 3Del Prato, S., Kahn, S. E., Pavo, I., et al. (2021). Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). The Lancet, 398(10313), 1811–1824.
- 4Malhotra, A., Grunstein, R. R., Gao, L., et al. (2024). Tirzepatide for the treatment of obstructive sleep apnea and obesity. New England Journal of Medicine, 391(13), 1193–1205.
- 5Caldow MK, Ham DJ, Trieu J, Chung JD, Lynch GS, Koopman R. Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice. Clinical Nutrition. 2016;35(5):1118–1126.
- 6Caldow MK, Ham DJ, Chee A, Trieu J, Naim T, Stapleton DI, Swiderski K, Lynch GS, Koopman R. Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling. Frontiers in Nutrition. 2019;6:172.
- 7Ham DJ, Gleeson BG, Chee A, Baum DM, Caldow MK, Lynch GS, Koopman R. L-Glycine Restores the Anabolic Response to Leucine in a Mouse Model of Acute Inflammation. American Journal of Physiology - Endocrinology and Metabolism. 2016;310(11):E970–E981.